|
Postmenopausal women who took a pill form of hormone replacement
therapy had an increase in a marker of heart attack risk,
while women who received the therapy from a patch did not,
according to a study.
While hormone replacement therapy was long thought to be
beneficial, recent trials have indicated that the therapy
may have a negative effect on the heart.
In the study, 21 postmenopausal women were divided into three
groups and given an estrogen patch, an oral estrogen pill
or a placebo. The groups were switched twice during the eight-week
study so that each group experienced all three therapies.
Previous studies have shown that oral estrogen administration
can increase levels of C-reactive protein, a marker for inflammation
that is linked to risk of heart attack and stroke.
In the current study, researchers found that levels of C-reactive
protein increased when women took the estrogen pill, but did
not change when women took a placebo or used the estrogen
patch.
Researchers suggest that the effects of estrogen depend on
how it is administered, but say that longer studies are needed
to prove whether the estrogen patch is safe over the long-term.
Journal
of the American College of Cardiology 2003;41:1358-1363
|